View in EDS HTML Full Text PDF Full Text

Targeting CXCR4/CXCL12 axis via [177Lu]Lu-DOTAGA.(SA.FAPi)2 with CXCR4 antagonist in triple-negative breast cancer.

Saved in:
Bibliographic Details
Title: Targeting CXCR4/CXCL12 axis via [177Lu]Lu-DOTAGA.(SA.FAPi)2 with CXCR4 antagonist in triple-negative breast cancer.
Authors: Bao, Guangfa1 (AUTHOR), Wang, Ziqiang1 (AUTHOR), Liu, Luoxia1 (AUTHOR), Zhang, Buchuan1 (AUTHOR), Song, Shuang1 (AUTHOR), Wang, Dongdong1 (AUTHOR), Cheng, Siyuan1 (AUTHOR), Moon, Eu-Song2 (AUTHOR), Roesch, Frank2 (AUTHOR), Zhao, Jun1,3,4 (AUTHOR), Yu, Bo1 (AUTHOR), Zhu, Xiaohua1 (AUTHOR) evazhu@vip.sina.com
Source: European Journal of Nuclear Medicine & Molecular Imaging. Jul2024, Vol. 51 Issue 9, p2744-2757. 14p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:16197070
DOI:10.1007/s00259-024-06704-y